National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$38.25
add to cart

Rights & Permissions

topleft topright

A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap (2006)
Board on Health Sciences Policy (HSP)
Space Studies Board (SSB)
Aeronautics and Space Engineering Board (ASEB)

Citation Manager

. "Appendix B Methods." A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA's Bioastronautics Roadmap. Washington, DC: The National Academies Press, 2006.

Please select a format:

BibTeX EndNote RefMan


Page
90
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


A Risk Reduction Strategy for Human Exploration of Space: A Review of NASA’s Bioastronautics Roadmap

INSTITUTE OF MEDICINE

AGENDA

Committee on Aerospace Medicine and Medicine in Extreme Environments

and

Committee on Review of NASA’s Bioastronautics

Critical Path Roadmap

Keck Building

500 5th Street, NW

Washington, DC

Room 110

Monday, April 12, 2004

CLOSED SESSION

(committee and staff only)

8:00 a.m.–12:00 p.m.

OPEN SESSION

12:00 p.m.

Lunch

1:00 p.m.

Request for a review of the Bioastronautics Critical Path Roadmap (BCPR)

Richard Williams, M.D., Chief Health and Medical Officer, NASA

1:10 p.m.

Overview of the Bioastronautics Critical Path Roadmap

NASA presenters: Guy Fogleman, director of bioastronautics research, Office of Biological and Physical Research; Howard Ross, acting deputy associate administrator for science, Office of Biological and Physical Research; Marc Shepanek, deputy chief, Medicine of Extreme Environments, NASA; Frank Sulzman, manager, Space Radiation Health Project

1:20 p.m.

How the Bioastronautics Critical Path Roadmap captures the critical risks and key research and technology issues for risk reduction, management, and informed decision making

Page
90